Alpine Immune Sciences Inc
ALPN
ALPN was delisted on the 17th of May, 2024.
38 hedge funds and large institutions have $22.3M invested in Alpine Immune Sciences Inc in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 22 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
24% less funds holding
Funds holding: 50 → 38 (-12)
55% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 22
78% less capital invested
Capital invested by funds: $100M → $22.3M (-$77.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$1.22M |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$938K |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$771K |
| 4 |
Millennium Management
New York
|
+$200K |
| 5 |
FO
FT Options
Chicago,
Illinois
|
+$174K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Axa
Paris,
France
|
-$5.3M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$3.98M |
| 3 |
Jennison Associates
New York
|
-$2.67M |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$1.79M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.66M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Bank of New York Mellon
New York
| – | -$134K | -4,124 | Closed |
|
|
DCM
52
DAFNA Capital Management
Los Angeles,
California
| – | -$122K | -3,750 | Closed |
|
|
TC
53
TFS Capital
West Chester,
Pennsylvania
| – | -$107K | -3,279 | Closed |
|
54
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$91K | -2,822 | Closed |
|
|
TG
55
TLP Group
Evanston,
Illinois
| – | -$91K | -2,788 | Closed |
|
|
AAP
56
Ardsley Advisory Partners
Stamford,
Connecticut
| – | -$81K | -2,500 | Closed |
|
57
UBS Group
Zurich,
Switzerland
| – | -$17K | -530 | Closed |
|
58
JP Morgan Chase
New York
| – | -$16K | -484 | Closed |
|
59
Bank of America
Charlotte,
North Carolina
| – | -$15K | -453 | Closed |
|
|
MTIP
60
Magee Thomson Investment Partners
San Diego,
California
| – | -$1K | -32 | Closed |
|
ALPN Hedge Fund Activity: Q4 2016 in Review
38 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q4 2016, worth a combined $22.3M — down 78% from $100M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of ALPN and 10 opened new positions — a net loss of 12 holders — while 7 trimmed existing stakes and 7 added.
The largest buyer was Panagora Asset Management, opening a new position worth an estimated $1.22M. The largest seller was Axa, exiting entirely with an estimated $5.3M sold.
- 38 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q4 2016, down from 50 in Q3 2016.
- Funds reported $22.3M of Alpine Immune Sciences Inc stock for Q4 2016, down 78% quarter-over-quarter.
- 10 funds opened new Alpine Immune Sciences Inc positions in Q4 2016 and 22 closed out, a net change of -12 holders.
- The largest Alpine Immune Sciences Inc buyer in Q4 2016 was Panagora Asset Management, an estimated $1.22M added.
- The largest Alpine Immune Sciences Inc seller in Q4 2016 was Axa, an estimated $5.3M sold.
Based on aggregated 13F filings for Q4 2016.